x

Coronavirus

US OKs Vaccine Materials for More Companies

WASHINGTON — White House officials say U.S. producers of vaccine materials and ingredients will no longer have to prioritize orders from three companies working on COVID-19 shots.

The change is expected to ease global shortages of key vaccine materials for overseas companies and governments.

Officials say the government is dropping its use of the Defense Production Act to prioritize supply orders from AstraZeneca, Novavax and Sanofi. Those three companies have not yet won U.S. authorization for their COVID-19 shots, despite receiving funding from the federal government for development and manufacturing.

Administration officials say the U.S. now has enough vaccines to protect all Americans. President Joe Biden has faced increasing pressure to make more U.S. vaccines and supplies available to struggling countries.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

Woman Fatally Shot while Pushing Stroller on Upper East Side

NEW YORK — A 20-year-old woman was fatally shot Wednesday night while she pushed her infant daughter in a stroller on the Upper East Side, police said.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.